ArticleRegional anesthesia and pain medicine2026
Wnt5a in keratinocytes contributes to complex regional pain syndrome through the activation of NR2B and MMP9 in rats.
Article in Regional anesthesia and pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplex regional pain syndrome (CRPS) is a chronic pain condition characterized by inflammatory features, though the underlying mechanisms remain partly understood. Our study examined whether Wnt5a in skin keratinocytes contributes to CRPS-related pain hypersensitivity by activating downstream N-methyl-D-aspartate receptor subunit 2B (NR2B) and matrix metalloproteinase-9 (MMP9) signaling in rats.
methodsWe developed a cell-culture model to mimic the local inflammation of CRPS and a rat model to mimic the chronic post-ischemia pain experienced by CRPS patients. Mechanical and heat pain thresholds in the hind paw were measured using an electronic von Frey apparatus and a radiant heat device. Western blotting and immunofluorescence were used to examine the expressions of NR2B and MMP9 in the skin and dorsal root ganglion (DRG), and immunofluorescence staining of connexin 43 (Cx43) and protein gene product 9.5 (PGP9.5) were conducted to explore the interaction between keratinocytes and nerve fibers in the skin.
resultsIn cell culture, Wnt5a was expressed in keratinocytes and contributed to cellular injury by increasing the levels of NR2B and MMP9. The mechanical and heat pain thresholds measured in the hind paw were decreased in CRPS rats, indicating increased pain sensitivity. The inhibition of Wnt5a alleviated these CRPS-related pain hypersensitivities. High levels of Cx43 and PGP9.5 staining were observed in the epidermis of CRPS rats, suggesting an interaction between keratinocytes and nerve fibers that may contribute to CRPS. Additionally, upregulations of NR2B and MMP9 in the DRG may further exacerbate pain.
conclusionsSkin keratinocytes may play an essential role in the pathophysiology of CRPS. Wnt5a signaling may increase pain sensitivity by upregulating downstream NR2B and MMP9, thereby contributing to CRPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.